Intervention for cerebral hypoxia for Cerebral Hypoxia

Phase-Based Progress Estimates
1
Effectiveness
2
Safety
Cerebral HypoxiaIntervention for cerebral hypoxia - Other
Eligibility
< 18
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether interventions based on NIRS monitoring can help improve outcomes for extremely premature infants.

Eligible Conditions
  • Cerebral Hypoxia

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: Birth until hospital discharge, an average of 3 months

Week 42
Rates of death or severe brain injury
Month 3
Rates of other neonatal morbidities
Hour 72
Frequency of interventions used to address cerebral hypoxia
Rates of cerebral hypoxia and systemic hypoxia

Trial Safety

Safety Progress

2 of 3
This is further along than 68% of similar trials

Trial Design

1 Treatment Group

Interventional Arm
1 of 1

Experimental Treatment

100 Total Participants · 1 Treatment Group

Primary Treatment: Intervention for cerebral hypoxia · No Placebo Group · Phase 2

Interventional Arm
Other
Experimental Group · 1 Intervention: Intervention for cerebral hypoxia · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: birth until hospital discharge, an average of 3 months

Who is running the clinical trial?

Valerie Chock, M.D., M.S. EpiLead Sponsor
Washington University School of MedicineOTHER
1,803 Previous Clinical Trials
2,279,349 Total Patients Enrolled
Cerebral Palsy AllianceOTHER
7 Previous Clinical Trials
912 Total Patients Enrolled
Valerie Chock, MDPrincipal InvestigatorStanford University
1 Previous Clinical Trials
111 Total Patients Enrolled
Zachary Vesoulis, MDPrincipal InvestigatorWashington University in Saint Louis

Eligibility Criteria

Age < 18 · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are a woman who has given birth to an infant less than 28 weeks of age.